Concert Pharmaceuticals Inc.

(CNCE) Trade

By |

Profile

Concert Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It aims to discover and develop small-molecule drugs for new treatments to cure cystic fibrosis, inflammation, narcolepsy, residual schizophrenia, and Alzheimer's agitation.

Contact Information

Website: www.concertpharma.com
Email: IR@concertpharma.com
Main Phone: +1 781 860-0045
Address: 99 Hayden Avenue
Address 2: Suite 500
State: MA
City / Town: Lexington
Country: USA
Postal Code: 02421

Issuer Information

Exchange: NSD
CEO: Roger D. Tung
Employees: 64
NAICS: Pharmaceutical Preparation Manufacturing(325412)
$ 13.81 $ -0.03 (-0.22%)
Last Price 13.81 Change $ -0.03 Change % -0.22 Tick N/A
Bid 11.14 Bid Size 100.00 Ask 15.10 Ask Size 100.00
Open 13.83 High 13.95 Low 13.70 Prev Close 13.84
Last Trade Volume 72,949 52 Wk Hi 30.71 52 Wk Low 12.33
Market Cap 323.4 mi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 23,415,025.00 EPS (TTM) 4.37 PE Ratio 3.20 Exchange NSD
  Last 3 Mo Last 12 Mo
Number of Insider Trades 11 60
Number of Buys 0 18
Number of Sells 11 42
Net Activity -49359 388297
Last 10 Buys Shares
Mark N. Lampert 1,000
Mark N. Lampert 1,000
Mark N. Lampert 1,000
Thomas G Auchincloss 1,000
Roger D. Tung 1,000
Last 10 Sell Shares
James V. Cassella 1,000
Richard H. Aldrich 1,000
Richard H. Aldrich 1,000
Richard H. Aldrich 1,000
Richard H. Aldrich 1,000
Richard H. Aldrich 1,000
Richard H. Aldrich 1,000
Richard H. Aldrich 1,000
Richard H. Aldrich 1,000
Richard H. Aldrich 1,000
  Current 1 Week Ago 2 Weeks Ago 3 Weeks Ago
High Target Price Estimate 27 27 27 27
Low Target Price Estimate 26 26 26 26
Mean Target Price Estimate 26.67 26.67 26.67 26.67
Standard Deviation 0.58 0.58 0.58 0.58
Date of Most Recent Estimate 05/04/18 05/04/18 05/04/18 05/04/18
  Current 1 Month Ago 2 Months Ago 3 Months Ago
Strong Buy 3 3 3 3
Moderate Buy 0 0 0 0
Hold 0 0 0 0
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 1 1 1 1